查詢結果分析
相關文獻
- 非小細胞肺癌術前輔助性化學治療的經驗
- The Role of Radiotherapy for Advanced Non-Small Cell Lung Cancer
- Differential Display of mRNA in Human Lung Tissue and in Non-Small Cell Lung Cancer: A Preliminary Report
- 非小細胞肺癌的治療
- 晚期非小細胞肺癌之化學治療
- CA405之基因療法合併化學抗癌藥物對肺癌細胞之作用效果評估與機轉的探討(2)
- Treatment of Non-Small-Cell Lung Cancer: The Chinese Experience in a General Teaching Hospital
- erbB基因與非小細胞肺癌的原發抗藥性
- Concurrent 5-Fluorouracil, Leucovorin, Etoposide, Cisplatin and Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Cytokeratin Fragment 19(Cyfra 21-1) as a Tumor Marker in Non-Small Cell Lung Cancer
頁籤選單縮合
題名 | Combined Modality Treatment of the Locally Advanced (Stage ⅢA-ⅢB) Non-Small Cell Lung Cancer=局部嚴重非小細胞肺癌(ⅢA-ⅢB期)之合併療法 |
---|---|
作者 | 黃經民; 林群書; 劉岱瑋; 任益民; Hwang, Jing-min; Lin, Chuan-shu; Liu, Dai-wei; Jen, Yee-min; |
期刊 | Journal of Medical Sciences |
出版日期 | 20030600 |
卷期 | 23:3 2003.06[民92.06] |
頁次 | 頁139-144 |
分類號 | 415.468 |
語文 | eng |
關鍵詞 | 非小細胞肺癌; Chemotherapy; Concurrent chemoradiotherapy; CCRT; Non-small cell lung cancer; NSCLC; Radiotherapy; 3-dimensional conformal radiotherapy; 3-D CRT; |
英文摘要 | Lung cancer has become the second leading cause of cancer deaths since 1997 in Taiwan area. Most of these are non-small cell lung cancer (NSCLC). Traditionally, patients with locally advanced NSCLC were treated with thoracic radiotherapy alone either with conventional or hyperfractionated regimen. Dose escalation of radiotherapy can improve local control and possible survival if the extrathoracic metastases is not existed or well controlled. The additional effects of combined new chemical agents and higher radiation dose may be possible to get a better treatment outcome without perplexing toxicity. On the basis of this strategy, chemotherapy in combination with radiotherapy using sequential, induction, or concurrent modalities combined with newer techniques of 3-dimensional conformal radiotherapy (3-D CRT) may provide additional survival benefit. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。